The Role of Epigenomics in the Study of Cancer Biomarkers and in the Development of Diagnostic Tools.

Verma, Mukesh

Verma, Mukesh.

Afiliação

Verma M; Epidemiology and Genomics Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute (NCI), National Institutes of Health (NIH), Suite# 4E102. 9609 Medical Center Drive, MSC 9763, Bethesda, MD, 20892-9726, USA. vermam@mail.nih.gov.

Adv Exp Med Biol ; 867: 59-80, 2015.

Article em En | MEDLINE | ID: mdl-26530360

Assuntos

Biomarcadores Tumorais/análise; Epigenômica; Neoplasias/diagnóstico; Humanos

Palavras-chave

Biomarker; Bladder cancer; Blood cancer; Brain cancer; Breast cancer; Cancer; Cancer epigenetics; Cervical cancer; Chromatin; Colorectal cancer; Diagnosis; Early detection; Endometrial cancer; Epigenetic inhibitors; Epigenetics; Epigenomic biomarkers; Gastric cancer; Genomic instability; Glioma; Head and neck cancer; Histone; Kidney cancer; Leukemia and lymphoma; Liver cancer; Lung cancer; Methylation; Ovarian cancer; Pancreatic cancer; Prognosis; Prostate cancer; Skin cancer; Surveillance; Validation; microRNA

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Epigenômica / Neoplasias Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Humans Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google